Poultry production with quality vs. antibiotic-free programs
Liliana Longo Borges & Melina Bonato (R&D, ICC Brazil)
The antibiotics withdrawal as performance enhancers and the rational use of the therapeutic form in animal production is a pressing issue all over the world, not only from consumers but also from the scientific community and international regulatory bodies. The United States, in January 2017, banned the use of any antimicrobial substance of importance in human medicine, and large companies of fast food market adhered to free antibiotic diets production, where antibiotics are no longer used even in the therapeutic form.
According to the WHO (2015), about 600 million, or nearly 1 in 10 people worldwide, become ill after consuming contaminated food. Of these, 420,000 people die, including 125,000 children under the age of five. Bacteria caused most cases of foodborne illnesses, and the most frequent serotypes were Salmonella spp, Escherichia coli and Staphylococcus aureus.
The impact of antibiotics on the gut microbiota has been more recently investigated, and researchers have shown that, in addition to altering the composition of the microbiota, antibiotics also can affect the gene expression, protein activity and the overall metabolism of the intestinal microbiota. Microbial changes caused by antibiotics, increase the immediate risk of infection and can also affect basic immunological homeostasis in long-term.
With this new reality, it is imperative that the production chain adapts and applies a strict plan of management, health, and nutrition, since the transmission could be by the ration, environment or even vertical (from the breeder to the chicken/laying hen), so proper management plan is essential in this control.
There are several alternatives on the market to control pathogenic bacteria, such as live attenuated vaccines (which act on Salmonella Gallinarum and Salmonella Typhimurium, also acting on Salmonella Enteritidis). Products that act on the feed as bactericidal antimicrobials, or that act on the animal organism, such as probiotics, organic acids, plant extracts, prebiotics, etc. Each product has a different mode of action, directly or indirectly, modulating the microbiota and the response of the immune system.
The yeast cell wall from Saccharomyces cerevisiae is one of the solutions that can help with the pathogen control program since it is a natural solution that helps to reduce the contamination and prevent the problem. Based on this concept, ImmunoWall® stands out from others products because is composed by a dense yeast cell wall of Saccharomyces cerevisiae with high concentrations of β-Glucans and MOS, resulting in a feed additive with proven results and great cost/benefit.
MOS is known for its capacity to agglutinate pathogens. It will prevent pathogen colonization in the gut as it offers a binding site to harmful bacteria that possess type 1 fimbriae present in the intestinal tract. Because the β-glucans are indigestible, the “trapped” bacteria will be excreted together with the fecal material. It is important to highlight that, to reach...
Do you already have an account? Log in here